Exclusivity Patents and exclusivity Drug Information Prescribing and other information DMFs Type 2 master files Databases Free access to database search 21 CFR FDA regulations for this API Federal Register FR search results for this API Drug Recalls For Rx's using this API

FDA Approval Activities for this Drug… Hydrochlorothiazide Capsules, 12.5 mg, Vintage ANDA 75-907 9/17/02 Hydrochlorothiazide Capsules, 12.5 mg, Mylan ANDA 75-640 1/28/00 2/4/00 Hydrochlorothiazide Tablets, 25 7 50 mg, Vintage ANDA 40-412 Micardis HCT (telmisartan / hydrochlorothiazide) Tablets, Boehringer Ingelheim | Fosinopril Sodium & Hydrochlorothiazide Tablets, Andrx Pharma, Approval | Aldoril (methyldopa/hydrochlorothiazide) Tablets, Merck & Company, Labeling Revision | Avalide (irbesartan/hydrochlorothiazide) Tablets, Sanofi-Synthelabo, Formulation Revision | Quinapril hydrochloride & Hydrochlorothiazide Tablets, Mylan Pharma, Approval | Zestoretic (lisinopril/hctz) Tablets, AstraZeneca Pharma, Labeling Revision | Diovan HCT (valsartan/ hydrochlorothiazide) Tablets, Novartis Pharma, Labeling Revision | Diovan HCT (valsartan/ hydrochlorothiazide) Tablets, Novartis Pharma, Labeling Revision | Teveten HCT (eprosartan mesylate/hydrochlorothiazide) tablets, Kos Life Sciences, Control Supplement | Hydrochlorothiazide Capsules, Ivax Pharma, Approval | Fosinopril Sodium & Hydrochlorothiazide Tablets, Watson Labs, Approval | MICARDIS HCT (telmisartan/hydrochlorothiazide) Tablets, Boehringer Ingelheim Pharma, Labeling Revision | Benazepril Hydrochloride & Hydrochlorothiazide Tablets, Ranbaxy, Approval | Fosinopril Sodium and Hydrochlorothiazide Tablets, Sandoz, Approval | Prinzide (lisinopril/hydrochlorothiazide) Tablets, Merck & Co., Labeling Revision | HYZAAR (losartan/potassium hydrochlorothiazide) Tablets, Merck Research, New Dosage Regimen | Avalide (irbesartan/hydrochlorothiazide) Tablets, Sanofi-Aventis, Labeling Revision | HYZAAR (losartan potassium hydrochlorothiazide) Tablets, Merck Research, Labeling Revision | Avalide (irbesartan-hydrochlorothiazide) Tablets, Sanofi-Aventis, Labeling | Avapro (irbesartan) Tablets, Sanofi-Aventis, Labeling Revision | Losartan Potassium and Hydrochlorothiazide Tablets, Teva Pharma, Tentative Approval | Prinzide (lisinopril/hctz) Tablets, Merck & Co., Labeling Revision | Zestoretic (lisinopril/hctz) Tablets, AstraZeneca Pharma, Labeling Revision | Fosinopril Sodium & Hydrochlorothiazide Tablets, Teva Pharma, Approval | Losartan Potassium & Hydrochlorothiazide Tablets, Roxane Labs, Tentative Approval | Fosinopril Sodium & Hydrochlorothiazide Tablets, Genpharm, Approval | Losartan Potassium & Hydrochlorothiazide Tablets, Roxane Labs, Tentative Approval | Hyzaar Tablet, Merck, Labeling Revision | Lopressor HCT (metoprolol tartrate and hydrochlorothiazide) Tablets, Novartis Pharma, Labeling Revision | Lisinopril & Hydrochlorothiazide Tablets, Lupin Ltd., Approval | Hyzaar (losartan potassium/hydrochlorothiazide) Tablets, Merck Research Labs, Labeling Revision | Inderide (propranolol hydrochloride and hydrochlorothiazide) Tablets, Wyeth Pharma, Labeling Revision | Lotensin HCT (benazepril HCl/hctz) Tablets, Novartis Pharma, Labeling Revision | Prinzide (lisinopril/hctz) Tablets, Merck & Co., Labeling Revision | Hydrochlorothiazide Tablets, Excellium Pharma, Approval Check the most up-to-date list of FDA Approvals.                                                                                      A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | FindingHealthOnline © 2010 Betterchem.com